299 related articles for article (PubMed ID: 3080584)
21. Gender differences in pulmonary arterial reactivity to dilatory agonists in pulmonary hypertension.
Packer CS; Johnson TC; Vijay P; Sharp TG; Jha D; Tighe SM; Chukwu HV
J Gend Specif Med; 2003; 6(3):30-8. PubMed ID: 14513574
[TBL] [Abstract][Full Text] [Related]
22. Ontogeny of vascular smooth muscle responsiveness in the postweaning rat.
Soltis EE; Newman PS
Dev Pharmacol Ther; 1992; 18(1-2):44-54. PubMed ID: 1483362
[TBL] [Abstract][Full Text] [Related]
23. Potassium chloride- and norepinephrine-induced contractile responses in rabbit pulmonary blood vessels.
Altiere RJ; Douglas JS; Gillis CN
J Pharmacol Exp Ther; 1983 Mar; 224(3):572-8. PubMed ID: 6827480
[TBL] [Abstract][Full Text] [Related]
24. [Changes in smooth muscle cell proliferation in pulmonary arteries of rats given monocrotaline].
Suzuki A; Kakusaka I; Kiyatake K; Nakano K; Kaneko N; Kuriyama T
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Feb; 33(2):109-13. PubMed ID: 7731112
[TBL] [Abstract][Full Text] [Related]
25. Altered function of pulmonary endothelium following monocrotaline-induced lung vascular injury in rats.
Ito K; Nakashima T; Murakami K; Murakami T
Br J Pharmacol; 1988 Aug; 94(4):1175-83. PubMed ID: 3145089
[TBL] [Abstract][Full Text] [Related]
26. Role of nitric oxide and endothelin-1 in monocrotaline-induced pulmonary hypertension in rats.
Mathew R; Zeballos GA; Tun H; Gewitz MH
Cardiovasc Res; 1995 Nov; 30(5):739-46. PubMed ID: 8595621
[TBL] [Abstract][Full Text] [Related]
27. Attenuated noradrenaline-induced contraction of pulmonary arteries from rats treated with monocrotaline: role of rho kinase.
Khan I; Oriowo MA; Chandrasekhar B; Kadavil EA
J Vasc Res; 2005; 42(5):433-40. PubMed ID: 16127279
[TBL] [Abstract][Full Text] [Related]
28. Enhanced vascular contractility and diminished coronary artery flow in rats made hypertensive from diet-induced obesity.
Boustany-Kari CM; Gong M; Akers WS; Guo Z; Cassis LA
Int J Obes (Lond); 2007 Nov; 31(11):1652-9. PubMed ID: 16819529
[TBL] [Abstract][Full Text] [Related]
29. Alterations in vascular structure and function after short-term losartan treatment in spontaneously hypertensive rats.
Soltis EE
J Pharmacol Exp Ther; 1993 Aug; 266(2):642-6. PubMed ID: 8355197
[TBL] [Abstract][Full Text] [Related]
30. Amlodipine inhibits the development of right ventricular hypertrophy and medial thickening of pulmonary arteries in a rat model of pulmonary hypertension.
Takahashi T; Kanda T; Imai S; Suzuki T; Kobayashi I; Nagai R
Res Commun Mol Pathol Pharmacol; 1996 Jan; 91(1):17-32. PubMed ID: 8824928
[TBL] [Abstract][Full Text] [Related]
31. [Effects of prostaglandin E1 (PGE1) on pulmonary hypertension and lung vascular remodeling in a rat monocrotaline model of human pulmonary hypertension].
Ono S; Tanita T; Hoshikawa Y; Song C; Maeda S; Tabata T; Noda M; Ueda S; Ashino Y; Fujimura S
Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Aug; 33(8):862-7. PubMed ID: 7474567
[TBL] [Abstract][Full Text] [Related]
32. Vascular hyperresponsiveness in perfused lungs from monocrotaline-treated rats.
Gillespie MN; Olson JW; Reinsel CN; O'Connor WN; Altiere RJ
Am J Physiol; 1986 Jul; 251(1 Pt 2):H109-14. PubMed ID: 2942040
[TBL] [Abstract][Full Text] [Related]
33. All-trans retinoic acid in pulmonary vascular structural remodeling in rats with pulmonary hypertension induced by monocrotaline.
Qin Y; Zhou A; Ben X; Shen J; Liang Y; Li F
Chin Med J (Engl); 2001 May; 114(5):462-5. PubMed ID: 11780404
[TBL] [Abstract][Full Text] [Related]
34. [Functional changes in the pulmonary arteries of pulmonary hypertensive rats].
Nakashima M
Bull Chest Dis Res Inst Kyoto Univ; 1982 Mar; 15(1-2):60-9. PubMed ID: 6927518
[No Abstract] [Full Text] [Related]
35. Strain differences in pulmonary hypertensive response to monocrotaline alkaloid and the beneficial effect of oral magnesium treatment.
Mathew R; Altura BT; Altura BM
Magnesium; 1989; 8(2):110-6. PubMed ID: 2526910
[TBL] [Abstract][Full Text] [Related]
36. Increased vascular responsiveness in lungs of rats with pulmonary hypertension induced by monocrotaline pyrrole.
Hilliker KS; Roth RA
Am Rev Respir Dis; 1985 Jan; 131(1):46-50. PubMed ID: 3966714
[TBL] [Abstract][Full Text] [Related]
37. Dose-response relationship in intoxication by the pyrrolizidine alkaloid monocrotaline.
Shubat PJ; Hubbard AK; Huxtable RJ
J Toxicol Environ Health; 1989; 28(4):445-60. PubMed ID: 2531804
[TBL] [Abstract][Full Text] [Related]
38. Responses to pressure and vasoactive agents by isolated pulmonary arteries from monocrotaline-treated rats.
Madden JA; Keller PA; Effros RM; Seavitte C; Choy JS; Hacker AD
J Appl Physiol (1985); 1994 Apr; 76(4):1589-93. PubMed ID: 8045836
[TBL] [Abstract][Full Text] [Related]
39. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension.
Rosenberg HC; Rabinovitch M
Am J Physiol; 1988 Dec; 255(6 Pt 2):H1484-91. PubMed ID: 3144186
[TBL] [Abstract][Full Text] [Related]
40. Angiotensin converting enzyme activity and evolution of pulmonary vascular disease in rats with monocrotaline pulmonary hypertension.
Kay JM; Keane PM; Suyama KL; Gauthier D
Thorax; 1982 Feb; 37(2):88-96. PubMed ID: 6281933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
